SuperworthNanoviricides shares outstanding NNVC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 22.3M
- On a year earlier
- +37.6%
- more shares
Nanoviricides had 22.3M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 37.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 22.3M | +38% |
| FY2025 | 16.2M | +32% |
| FY2024 | 12.2M | +5% |
| FY2023 | 11.7M | +1% |
| FY2022 | 11.6M | +0% |
| FY2021 | 11.5M | +39% |
| FY2020 | 8.3M | +116% |
| FY2019 | 3.8M | +11% |
| FY2018 | 3.4M | +9% |
| FY2017 | 3.2M | +9% |
| FY2016 | 2.9M | +1% |
| FY2015 | 2.9M | +6% |
| FY2014 | 2.7M | +16% |
| FY2013 | 2.3M | +5% |
| FY2012 | 2.2M | +9% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 22.3M | +38% | |
| Q3 FY26 | 21.6M | +35% | |
| Q2 FY26 | 19.9M | +36% | |
| Q1 FY26 | 17.1M | +25% | |
| Q4 FY25 | 16.2M | +32% | |
| Q3 FY25 | 16M | +36% | |
| Q2 FY25 | 14.6M | +24% | |
| Q1 FY25 | 13.7M | +17% | |
| Q4 FY24 | 12.2M | +5% | |
| Q3 FY24 | 11.8M | +1% | |
| Q2 FY24 | 11.7M | +1% | |
| Q1 FY24 | 11.7M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Nanoviricides
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.